{"id":"https://openalex.org/W2015882996","doi":"https://doi.org/10.2165/00019053-200220010-00001","title":"Economic Evaluation of Vaccination Programmes","display_name":"Economic Evaluation of Vaccination Programmes","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2015882996","doi":"https://doi.org/10.2165/00019053-200220010-00001","mag":"2015882996","pmid":"https://pubmed.ncbi.nlm.nih.gov/11817988"},"language":"en","primary_location":{"id":"doi:10.2165/00019053-200220010-00001","doi":"https://doi.org/10.2165/00019053-200220010-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-200220010-00001","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059507519","display_name":"Philippe Beutels","orcid":"https://orcid.org/0000-0001-5034-3595","observed_orcids":["https://orcid.org/0000-0001-5034-3595"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Philippe Beutels","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium. philippe.beutels@ua.ac.be","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium. philippe.beutels@ua.ac.be","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001383313","display_name":"W. John Edmunds","orcid":"https://orcid.org/0000-0002-9179-2917","observed_orcids":["https://orcid.org/0000-0002-9179-2917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. John Edmunds","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108429840","display_name":"Fernando Anto anzas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernando Anto??anzas","raw_affiliation_strings":["Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054284981","display_name":"G. Ardine de Wit","orcid":"https://orcid.org/0000-0002-1375-7657","observed_orcids":["https://orcid.org/0000-0002-1375-7657","https://orcid.org/0000-0001-7911-8850"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Ardine de Wit","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Evans","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036609903","display_name":"Richard Feilden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Feilden","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087546386","display_name":"A. Mark Fendrick","orcid":"https://orcid.org/0000-0002-7734-6742","observed_orcids":["https://orcid.org/0000-0002-7734-6742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Mark Fendrick","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035525498","display_name":"Gary Michael Ginsberg","orcid":"https://orcid.org/0000-0001-6756-1900","observed_orcids":["https://orcid.org/0000-0001-6756-1900","https://orcid.org/0000-0003-1315-890X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary M. Ginsberg","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108792869","display_name":"Henry A. Glick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry A. Glick","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066811634","display_name":"Eric E. Mast","orcid":"https://orcid.org/0000-0002-8762-9287","observed_orcids":["https://orcid.org/0000-0002-8762-9287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Mast","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096890242","display_name":"Marc P chevis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc P??chevis","raw_affiliation_strings":["Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056551664","display_name":"Eddy K.A. van Doorslaer","orcid":"https://orcid.org/0000-0003-2692-1433","observed_orcids":["https://orcid.org/0000-0003-2692-1433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eddy K.A. Van Doorslaer","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061316225","display_name":"Ben A. van Hout","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ben A. van Hout","raw_affiliation_strings":["Viral Hepatitis Prevention Board, Antwerp, Belgium","Viral Hepatitis Prevention Board"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viral Hepatitis Prevention Board, Antwerp, Belgium","institution_ids":[]},{"raw_affiliation_string":"Viral Hepatitis Prevention Board","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5059507519"],"corresponding_institution_ids":[],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":24.2369,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.99347194,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"20","issue":"1","first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunization-programs","display_name":"immunization programs","score":0.8769999742507935},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hepatitis-b-vaccination","display_name":"hepatitis B vaccination","score":0.7250000238418579},{"id":"https://openalex.org/keywords/hepatitis-a-vaccination","display_name":"hepatitis A vaccination","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.5680000185966492},{"id":"https://openalex.org/keywords/model-selection","display_name":"model selection","score":0.4650000035762787},{"id":"https://openalex.org/keywords/neonatal-vaccination","display_name":"neonatal vaccination","score":0.578000009059906},{"id":"https://openalex.org/keywords/viral-hepatitis","display_name":"viral hepatitis","score":0.3790000081062317},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.8387593626976013},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6508095264434814},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.5743073225021362},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.5353406667709351},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.44883012771606445},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.44417059421539307},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.44167396426200867},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.42626050114631653},{"id":"https://openalex.org/C2780233690","wikidata":"https://www.wikidata.org/wiki/Q535347","display_name":"Transparency (behavior)","level":2,"score":0.4161509573459625},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3461952209472656},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19704687595367432},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.18910762667655945},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1275327205657959},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.10909852385520935},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.09403669834136963},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006302","descriptor_name":"Health Services Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006506","descriptor_name":"Hepatitis A","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006506","descriptor_name":"Hepatitis A","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014943","descriptor_name":"Global Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017325","descriptor_name":"Hepatitis B Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017325","descriptor_name":"Hepatitis B Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D017589","descriptor_name":"Immunization Programs","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D022362","descriptor_name":"Hepatitis A Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D022362","descriptor_name":"Hepatitis A Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2165/00019053-200220010-00001","doi":"https://doi.org/10.2165/00019053-200220010-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-200220010-00001","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:11817988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11817988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Consensus Statement"},{"id":"pmh:eur:oai:pure.eur.nl:publications/64b9ff35-1536-4d8b-b6e2-756cc5f76fe6","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/64b9ff35-1536-4d8b-b6e2-756cc5f76fe6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PharmacoEconomics, 20(1), 1 - 7. Adis","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/64b9ff35-1536-4d8b-b6e2-756cc5f76fe6","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/64b9ff35-1536-4d8b-b6e2-756cc5f76fe6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Beutels, P, Edmunds, W J, Anto\u00f1anzas, F, De Wit, G A, Evans, D, Feilden, R, Fendrick, A M, Ginsberg, G M, Henry, G A, Mast, E, P\u00e9chevis, M, Van Doorslaer, E K A & van Hout, B A 2002, 'Economic evaluation of vaccination programmes : A consensus statement focusing on viral hepatitis', PharmacoEconomics, vol. 20, no. 1, pp. 1-7. https://doi.org/10.2165/00019053-200220010-00001","raw_type":"info:eu-repo/semantics/review"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1554104503","https://openalex.org/W1606697907","https://openalex.org/W2001346890","https://openalex.org/W2001622435","https://openalex.org/W2009057398","https://openalex.org/W2043951092","https://openalex.org/W2045371142","https://openalex.org/W2064053774","https://openalex.org/W2083449041","https://openalex.org/W2092123927","https://openalex.org/W2107905788","https://openalex.org/W2143953565","https://openalex.org/W2160636503","https://openalex.org/W2414081036","https://openalex.org/W2936971050","https://openalex.org/W3024845472","https://openalex.org/W4244536823","https://openalex.org/W4302313952"],"related_works":["https://openalex.org/W7056182579","https://openalex.org/W1483249507","https://openalex.org/W2001622435","https://openalex.org/W1973699073","https://openalex.org/W1976835530","https://openalex.org/W2111952892","https://openalex.org/W2158517305","https://openalex.org/W3205453367","https://openalex.org/W7095966318","https://openalex.org/W1513095079"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}